Effects of a Multifaceted Teleguided Pain Care Program in Patients With Cancer Pain
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pain
- Sponsor
- Maastricht University Medical Center
- Enrollment
- 174
- Locations
- 2
- Primary Endpoint
- Change in pain intensity (Brief Pain Inventory - Short Form (BPI-SF)
- Last Updated
- 11 years ago
Overview
Brief Summary
Pain is a prevalent and distressing symptom in patients with cancer, having an enormous impact on functioning and quality of life. Integration of patient self-management and professional care by means of care technology provides new opportunities in the outpatient setting. In this project a technology based and nurse delivered multicomponent self-management support intervention has been developed. Important components include monitoring, feedback, education, and nurse support. Following feasibility evaluation, the primary aim of this randomized controlled trial is to assess the effect of the intervention regarding pain intensity and quality of life as compared to care as usual. Secondary outcomes of the effect evaluation are self-efficacy, knowledge, anxiety and depression, and pain medication use. Besides, a cost-evaluation and summative process evaluation will be performed.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of cancer
- •Patients who are under (palliative) anti-tumour treatment in a day clinic or outpatient clinic, or patients who have no treatment options available anymore
- •Cancer (treatment related) pain \> 2 weeks
- •Pain is defined as a patient reported pain score of 4 or more on a numerical rating scale (scale 0-10)
- •Living at home
Exclusion Criteria
- •Expected life expectancy \< 3 months
- •Chronic non-cancer pain
- •Known cognitive impairments
- •Participation in other studies that interfere with this study
- •Not being able to read and understand the Dutch language
- •Reduced vision
- •Non-reachable by phone
Outcomes
Primary Outcomes
Change in pain intensity (Brief Pain Inventory - Short Form (BPI-SF)
Time Frame: 12 weeks
As measured with the Brief Pain Inventory - Short Form (BPI-SF)
Change in cancer related quality of life (European Organisation for Research and Treatment of Cancer Quality of life Questionnaire (EORTC QLQ-C30 version 3)
Time Frame: 12 weeks
As measured with the European Organisation for Research and Treatment of Cancer Quality of life Questionnaire (EORTC QLQ-C30 version 3)
Secondary Outcomes
- Change in self-efficacy (Chronic Pain Self-efficacy Scale (CPSS)(12 weeks)
- Change in knowledge about cancer pain (Pain Knowledge Questionnaire (PKQ)(12 weeks)
- Change in anxiety and depression (Hospital Anxiety and Depression Scale (HADS)(12 weeks)
- Change in pain medication use (Brief Pain Inventory - Short Form (BPI-SF), a cost diary and a pharmacist's overview)(12 weeks)